Drug
Andrographolide clinical trials
How studies write it
Studies that test it under each name
Studies by the year they started
3 studies that test it; most in 2013 (2)
| Year | Studies |
|---|---|
| 2006 | 1 |
| 2013 | 2 |
By phase
A phase 1/2 study counts in both.
What it is tested for
Each study’s main condition, where its own words name it.
Who runs them
Industry 3 · Other 0
Often tested with
Tested in the same studies.
Studies
Open first, then newest update. How each study uses andrographolide is read from its arms, and is right about nine times in ten.
Testing it · 3
- HMPL-004 Maintenance Treatment in Subjects With Mild to Moderate Ulcerative ColitisTerminatedPhase 3Hutchison Medipharma LimitedNCT01882764Written as HMPL-004
- Phase II Study of HMPL-004 in Subjects With Crohn's DiseaseCompletedPhase 2Hutchison Medipharma LimitedNCT00655733Written as HMPL-004
- A Phase III Trial of HMPL-004 in Patients With Mild to Moderate Active Ulcerative ColitisTerminatedPhase 3Hutchison Medipharma LimitedNCT01805791Written as HMPL-004 1800 mg/day
Codes
What other systems call andrographolide · ClinicalTrials.gg INT002921
- MeSH (NLM) C030419andrographolideConfirmed ClinicalTrials.gov, NLM, Wikidata
- UNII (FDA) 410105JHGRANDROGRAPHOLIDEConfirmed FDA, NLM, Wikidata
- Wikidata Q4759444andrographolideConfirmed FDA, NLM, Wikidata
- NCI Thesaurus C61637AndrographolideOne source FDA
- DrugBank DB05767One source Wikidata
| System | Code | Name there | Checked by |
|---|---|---|---|
| MeSH (NLM) | C030419 | andrographolide | Confirmed ClinicalTrials.gov, NLM, Wikidata |
| UNII (FDA) | 410105JHGR | ANDROGRAPHOLIDE | Confirmed FDA, NLM, Wikidata |
| Wikidata | Q4759444 | andrographolide | Confirmed FDA, NLM, Wikidata |
| NCI Thesaurus | C61637 | Andrographolide | One source FDA |
| DrugBank | DB05767 | — | One source Wikidata |
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.